AYRO, Inc. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
AYRO, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • AYRO, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.96M, a 36.8% increase year-over-year.
  • AYRO, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$25.3M, a 1.87% decline year-over-year.
  • AYRO, Inc. annual Operating Income (Loss) for 2023 was -$28.2M, a 21% decline from 2022.
  • AYRO, Inc. annual Operating Income (Loss) for 2022 was -$23.3M, a 29.7% increase from 2021.
  • AYRO, Inc. annual Operating Income (Loss) for 2021 was -$33.1M, a 228% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$28.2M -$4.88M -21% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$23.3M +$9.85M +29.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$33.1M -$23M -228% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$10.1M -$1.61M -19% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 -$8.49M -$6.26M -281% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$2.23M +$4.08M +64.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$6.31M -$3.77M -148% Jan 1, 2017 Dec 31, 2017 10-K/A 2019-04-12
2016 -$2.54M +$1.49M +36.9% May 1, 2016 Apr 30, 2017 10-K 2017-07-21
2015 -$4.03M -$2.96M -277% May 1, 2015 Apr 30, 2016 10-K 2017-07-21
2014 -$1.07M +$2.86M +72.8% May 1, 2014 Apr 30, 2015 10-K 2016-07-28
2013 -$3.93M -$3.66M -1342% May 1, 2013 Apr 30, 2014 10-K 2015-07-29
2012 -$273K +$13.8M +98.1% May 1, 2012 Apr 30, 2013 10-K 2014-07-30
2011 -$14M +$24.2M +63.3% May 1, 2011 Apr 30, 2012 10-K 2013-07-29
2010 -$38.2M May 1, 2010 Apr 30, 2011 10-K 2012-07-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.